Do gabapentin or pregabalin directly modulate the µ receptor?
Background Pregabalin and gabapentin improve neuropathic pain symptoms but there are emerging concerns regarding their misuse. This is more pronounced among patients with substance use disorder, particularly involving opioids. Co-ingestion of gabapentinoids with opioids is increasingly identified in...
Prif Awduron: | Preeti Manandhar, Bridin Patricia Murnion, Natasha L. Grimsey, Mark Connor, Marina Santiago |
---|---|
Fformat: | Erthygl |
Iaith: | English |
Cyhoeddwyd: |
PeerJ Inc.
2021-04-01
|
Cyfres: | PeerJ |
Pynciau: | |
Mynediad Ar-lein: | https://peerj.com/articles/11175.pdf |
Eitemau Tebyg
-
Gabapentin and pregabalin exposures reported to United States poison centers, 2012–2022
gan: Emily J.R. Carter, et al.
Cyhoeddwyd: (2024-11-01) -
A Systematic Review of the Clinical Use of Gabapentin and Pregabalin in Bipolar Disorder
gan: Qin Xiang Ng, et al.
Cyhoeddwyd: (2021-08-01) -
Efficacy and safety of pregabalin and gabapentin in spinal stenosis: a systematic review and meta-analysis
gan: Telmo Martínez, et al.
Cyhoeddwyd: (2023-11-01) -
Characterization of hospitalized patients who received naloxone while receiving opioids with or without gabapentinoids
gan: Payal H. Desai, PharmD, BCCCP, et al.
Cyhoeddwyd: (2021-07-01) -
Gabapentin and Pregabalin in chronic neuropathic pain: cost efficacy evaluation
gan: Paolo Marchettini, et al.
Cyhoeddwyd: (2005-05-01)